JNCE News
Archived Headlines
- 7 US IPOs join next week's calendar; 2 deals launch Wednesday morning for week of 1/30 01/18/17
- Immunotherapy biotech Jounce Therapeutics sets terms for $75 million IPO 01/17/17
- US IPO Week Ahead: Oilfield services company set to kick off 2017 01/13/17
- US IPO Week Ahead: Tech unicorn AppDynamics leads pack of potential IPO launches 01/06/17
- US IPO Weekly Recap: Out with the old, in with the new 12/30/16
See more
Biotechs stage comeback after slow quarter
The US IPO market snapped back in the 1Q17, but quarterly biotech activity fell to its lowest level since the 4Q12. Just three of the 25 deals came from biotechs in the 1Q17, compared to seven of the eight in the 1Q16. Recent IPO Tocagen (TOCA)...read more
US IPO Weekly Recap: AppDynamics taken out, 6 IPOs price
The star was taken, but the show must go on. Six companies went public this week, but AppDynamics (APPD) was notably missing as Cisco (Nasdaq: CSCO) acquired it for $3.7 billion the night before its scheduled pricing. Cisco paid a 68%...read more
Jounce Therapeutics prices upsized IPO at $16 to advance cancer immunotherapies with Celgene
Jounce Therapeutics, an early-stage biotech developing T cell immuno-oncology therapies with Celgene, raised $102 million by offering 6.4 million shares at $16, above the range of $13 to $15. Jounce Therapeutics plans to list on the Nasdaq under the symbol...read more
US IPO Week Ahead: AppDynamics headlines rush of 8 IPOs
There are eight IPOs scheduled for the week ahead, which would tie the most active week of 2016. Software provider AppDynamics (APPD) leads the pack; as the ...read more